The country manager of Pfizer Czech Republic reviews the advantages of Pfizer’s highly differentiated pipeline and points out how it will impact the success of the Czech affiliate in the future. Furthermore, he describes how he plans to position Pfizer as partner to the relevant stakeholders in order to utilize synergies for the benefit of all stakeholders in the country.
After 17 years in Pfizer you have assumed position as general manager for Czech Republic, supervisor for Hungary and Global Innovative Pharma business lead starting March this year – congratulations on these positions! Could you please briefly introduce yourself to our readership?
Our core essence is bringing new medicine and innovative treatments to all of the markets we’re active in; we will continue to do so, especially in the Czech Republic.
